SightLine Partners is an investment firm that manages venture funds primarily focused on late-stage medical technology and healthcare companies. They engage in venture capital, secondary buyouts, and joint venture transactions, often providing financial alternatives and follow-on capital to existing investors in growth-stage healthcare companies.
100% of their portfolio is in Healthcare. Their most common stage is series-c (50% of deals). Average disclosed round size is $42.4M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Magnolia Medical Technologies | Growth | $46M | Feb 2022 |
| Magnolia Medical Technologies | Series C | $20M | Jan 2019 |
| EEndoGastric Solutions | Series B | $30.5M | Jul 2018 |
 Earlens Corporation, Inc. | Series C | $73M | Jun 2017 |
Top Co-Investors
HealthQuest Capital2 shared
CRG2 shared
Sectoral Asset Management1 shared
Janus Henderson Investors1 shared
Evidity Health Capital1 shared
Advanced Technology Ventures1 shared
Canaan Partners1 shared
Chicago Ventures1 shared
Radius Capital1 shared
NEA (New Enterprise Associates)1 shared
Windham Venture Partners1 shared
Lightstone Ventures1 shared
Medtronic1 shared
RTW Investments1 shared
Last updated: 10 April 2026